These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 62817

  • 1. Modulation of the alternative complement pathways by beta 1 H globulin.
    Whaley K, Ruddy S.
    J Exp Med; 1976 Nov 02; 144(5):1147-63. PubMed ID: 62817
    [Abstract] [Full Text] [Related]

  • 2. C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.
    Whaley K, Schur PH, Ruddy S.
    J Clin Invest; 1976 Jun 02; 57(6):1554-63. PubMed ID: 819459
    [Abstract] [Full Text] [Related]

  • 3. Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.
    Pangburn MK, Schreiber RD, Müller-Eberhard HJ.
    J Exp Med; 1977 Jul 01; 146(1):257-70. PubMed ID: 301546
    [Abstract] [Full Text] [Related]

  • 4. A molecular concept of the properdin pathway.
    Medicus RG, Schreiber RD, Götze O, Müller-Eberhard HJ.
    Proc Natl Acad Sci U S A; 1976 Feb 01; 73(2):612-6. PubMed ID: 54923
    [Abstract] [Full Text] [Related]

  • 5. Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase.
    Fearon DT, Austen KF.
    J Exp Med; 1975 Oct 01; 142(4):856-63. PubMed ID: 1185108
    [Abstract] [Full Text] [Related]

  • 6. Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway.
    Medicus RG, Götze O, Müller-Eberhard HJ.
    J Exp Med; 1976 Oct 01; 144(4):1076-93. PubMed ID: 978134
    [Abstract] [Full Text] [Related]

  • 7. Complement C3 convertase: cell surface restriction of beta1H control and generation of restriction on neuraminidase-treated cells.
    Pangburn MK, Müller-Eberhard HJ.
    Proc Natl Acad Sci U S A; 1978 May 01; 75(5):2416-20. PubMed ID: 276881
    [Abstract] [Full Text] [Related]

  • 8. Complement receptor binding of C3b-coated cells treated with C3b inactivator, beta 1H globulin and trypsin.
    Carlo JR, Ruddy S, Studer EJ, Conrad DH.
    J Immunol; 1979 Aug 01; 123(2):523-8. PubMed ID: 88474
    [Abstract] [Full Text] [Related]

  • 9. Activation of the alternative complement pathway with rabbit erythrocytes by circumvention of the regulatory action of endogenous control proteins.
    Fearon DT, Austen KF.
    J Exp Med; 1977 Jul 01; 146(1):22-33. PubMed ID: 559720
    [Abstract] [Full Text] [Related]

  • 10. Purification of C3b inactivator and demonstration of its two polypeptide chain structure.
    Fearon DT.
    J Immunol; 1977 Oct 01; 119(4):1248-52. PubMed ID: 894033
    [Abstract] [Full Text] [Related]

  • 11. Control of the amplification convertase of complement by the plasma protein beta1H.
    Weiler JM, Daha MR, Austen KF, Fearon DT.
    Proc Natl Acad Sci U S A; 1976 Sep 01; 73(9):3268-72. PubMed ID: 1067618
    [Abstract] [Full Text] [Related]

  • 12. Requirements for beta1H globulin and C3b inactivator in the control of the alternative complement pathway in human serum.
    Whaley K, Thompson RA.
    Immunology; 1978 Dec 01; 35(6):1045-9. PubMed ID: 83964
    [Abstract] [Full Text] [Related]

  • 13. Purification of the human complement control protein C3b inactivator.
    Crossley LG, Porter RR.
    Biochem J; 1980 Oct 01; 191(1):173-82. PubMed ID: 6451220
    [Abstract] [Full Text] [Related]

  • 14. Properdin- and nephritic factor-dependent C3 convertases: requirement of native C3 for enzyme formation and the function of bound C3b as properdin receptor.
    Schreiber RD, Medicus RG, Gïtze O, Müller-Eberhard HJ.
    J Exp Med; 1975 Sep 01; 142(3):760-72. PubMed ID: 1165475
    [Abstract] [Full Text] [Related]

  • 15. Modulation of C3b hemolytic activity by a plasma protein distinct from C3b inactivator.
    Whaley K, Ruddy S.
    Science; 1976 Sep 10; 193(4257):1011-3. PubMed ID: 948757
    [Abstract] [Full Text] [Related]

  • 16. Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.
    Fearon DT, Daha MR, Strom TB, Weiler JM, Carpenter CB, Austen KF.
    Transplant Proc; 1977 Mar 10; 9(1):729-39. PubMed ID: 325806
    [Abstract] [Full Text] [Related]

  • 17. Relative importance of C3b inactivator and beta 1H globulin in the modulation of the properdin amplification loop in systemic lupus erythematosus.
    Whaley K, Schur PH, Ruddy S.
    Clin Exp Immunol; 1979 Jun 10; 36(3):408-14. PubMed ID: 114347
    [Abstract] [Full Text] [Related]

  • 18. Initiation of C3 cleavage in the alternative complement pathway.
    Fearon DT, Austen KF.
    J Immunol; 1975 Nov 10; 115(5):1357-61. PubMed ID: 809512
    [Abstract] [Full Text] [Related]

  • 19. Action of the C3b-inactivator on the cell-bound C3b.
    Law SK, Fearon DT, Levine RP.
    J Immunol; 1979 Mar 10; 122(3):759-65. PubMed ID: 448074
    [Abstract] [Full Text] [Related]

  • 20. Alternative pathway of complement: demonstration and characterization of initiating factor and its properdin-independent function.
    Schreiber RD, Götze O, Müller-Eberhard HJ.
    J Exp Med; 1976 Oct 01; 144(4):1062-75. PubMed ID: 62010
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.